✦ LIBER ✦

The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial

✍ Scribed by Uwe Zeymer; Harry Suryapranata; Jean Pierre Monassier; Grzegorz Opolski; John Davies; Gundars Rasmanis; Gerard Linssen; Ulrich Tebbe; Rolf Schröder; Rolf Tiemann; Thomas Machnig; Karl-Ludwig Neuhaus

Book ID: 119542567
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 100 KB
Volume: 38
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(01)01608-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary experience with intravenous

Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: Results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial

✍ Adam B. Greenbaum; E. Magnus Ohman; C. Michael Gibson; Steven Borzak; Amanda L. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Effect of Intravenous FX06 as an Adjunct

Effect of Intravenous FX06 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction: Results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) Trial

✍ Dan Atar; Peter Petzelbauer; Jürg Schwitter; Kurt Huber; Benno Rensing; Jaroslaw 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 323 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)

✍ Ik-Kyung Jang; Neil J. Weissman; Michael H. Picard; Michael R. Zile; Veronica Pe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Safety and feasibility of adjunctive ant

Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial

✍ Jeffrey S. Berger; Matthew T. Roe; C. Michael Gibson; Rakhi Kilaru; Cynthia L. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 239 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 219 KB